Filtered By:
Vaccination: Vaccines
Countries: Wales Health
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 768 results found since Jan 2013.
COVID-19 Vaccine Uptake by Infection Status in New South Wales, Australia
Emerg Infect Dis. 2023 Apr 4;29(5). doi: 10.3201/eid2905.230047. Online ahead of print.ABSTRACTUsing linked public health data from Australia to measure uptake of COVID-19 vaccination by infection status, we found coverage considerably lower among infected than uninfected persons for all ages. Increasing uptake of scheduled doses, including among previously infected persons after the recommended postinfection delay, is needed to reduce COVID-19 illness rates.PMID:37015284 | DOI:10.3201/eid2905.230047
Source: Emerging Infectious Diseases - April 4, 2023 Category: Infectious Diseases Authors: Heather F Gidding Sandrine Stepien Jiahui Qian Kristine K Macartney Bette Liu Source Type: research
Associations between severe and notifiable respiratory infections during the first trimester of pregnancy and congenital anomalies at birth: a register-based cohort study
CONCLUSION: This large population-based study found severe acute respiratory infection in first trimester of pregnancy was associated with a higher risk of selected major cardiovascular anomalies in babies. These findings support measures to prevent acute respiratory infections in pregnant women including through vaccination.PMID:36964492 | PMC:PMC10037767 | DOI:10.1186/s12884-023-05514-8
Source: Herpes - March 25, 2023 Category: Infectious Diseases Authors: Abrar A Chughtai Wen-Qiang He Bette Liu Source Type: research
Pregnancy-associated gynecological cancer in New South Wales, Australia 1994-2013: A population-based historical cohort study
CONCLUSIONS: The incidence of PAGC has not increased over time perhaps reflecting, in part, the effectiveness of cervical screening and early impacts of human papillomavirus vaccination programs in Australia. The higher rate of preterm birth among the gestational PAGC group is associated with adverse outcomes in babies born to these women.PMID:36915236 | DOI:10.1111/aogs.14530
Source: Cancer Control - March 14, 2023 Category: Cancer & Oncology Authors: Penelope Fotheringham Nadom Safi Zhouyang Li Antoinette Anazodo Marc Remond Andrew Hayen David Currow David Roder Nada Hamad Michael Nicholl Adrienne Gordon Jane Frawley Elizabeth A Sullivan Source Type: research
An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017
CONCLUSIONS: Findings of this study suggest that LAIV vaccination of primary school age children is associated with population-level benefits, particularly in reducing infection incidence in primary care.PMID:36824392 | PMC:PMC9942272 | DOI:10.1111/irv.13099
Source: Respiratory Care - February 24, 2023 Category: Respiratory Medicine Authors: Mary A Sinnathamby Fiona Warburton Arlene J Reynolds Simon Cottrell Mark O'Doherty Lisa Domegan Joan O'Donnell Jillian Johnston Ivelina Yonova Suzanne Elgohari Nicola L Boddington Nick Andrews Joanna Ellis Simon de Lusignan Jim McMenamin Richard G Pebody Source Type: research
COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study
CONCLUSION: Vaccination uptake was consistently lower among black HCWs, as well as those from deprived areas. Whilst breakthrough infections were highest in households with children.PMID:36669966 | DOI:10.1016/j.vaccine.2023.01.023
Source: Vaccine - January 20, 2023 Category: Allergy & Immunology Authors: Stuart Bedston Emily Lowthian Christopher I Jarvis Ashley Akbari Jillian Beggs Declan Bradley Simon de Lusignan Rowena Griffiths Laura Herbert Richard Hobbs Steven Kerr Jane Lyons William Midgley Rhiannon K Owen Jennifer K Quint Ruby Tsang Fatemeh Torabi Source Type: research
A case-crossover study of the effect of vaccination on SARS-CoV-2 transmission relevant behaviours during a period of national lockdown in England and Wales
Vaccine. 2022 Dec 5:S0264-410X(22)01497-9. doi: 10.1016/j.vaccine.2022.11.073. Online ahead of print.NO ABSTRACTPMID:36496282 | DOI:10.1016/j.vaccine.2022.11.073
Source: Vaccine - December 10, 2022 Category: Allergy & Immunology Authors: Aimee Serisier Sarah Beale Yamina Boukari Susan Hoskins Vincent Nguyen Thomas Byrne Wing Lam Erica Fong Ellen Fragaszy Cyril Geismar Jana Kovar Alexei Yavlinsky Andrew Hayward Robert W Aldridge Source Type: research
Factors associated with Q fever vaccination in Australian wildlife rehabilitators
This study aimed to determine factors associated with QFV status and describe AWR attitudes and potential barriers towards QFV. Data were obtained from a nationwide, online, cross-sectional survey of AWR undertaken in 2018. Approximately-three quarters (200/265; 75.5 %) of those that had heard of Q fever were also aware of the Q fever vaccine, and of those, 25.5 % (51/200) were vaccinated. Barriers to QFV, among unvaccinated respondents who had also heard of Q fever and the vaccine (149/200; 74.5 %), included concerns regarding the safety, efficacy, and importance of the Q fever vaccine. Complacency toward vaccination, con...
Source: Vaccine - November 24, 2022 Category: Allergy & Immunology Authors: Karen O Mathews Jacqueline M Norris David Phalen Nick Malikides Cathie Savage Paul A Sheehy Katrina L Bosward Source Type: research
Viruses, Vol. 14, Pages 2576: Epidemiological Aspects of Equid Herpesvirus-Associated Myeloencephalopathy (EHM) Outbreaks
This study confirms earlier suspected host-specific risk factors, and our data support the benefit of high vaccine coverage at high-traffic boarding facilities.
Source: Viruses - November 21, 2022 Category: Virology Authors: Eva Klouth Yury Zablotski Jessica L. Petersen Marco de Bruijn Gittan Gr öndahl Susanne M üller Lutz S. Goehring Tags: Article Source Type: research
Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales
DISCUSSION: Nirsevimab has the potential to be cost-effective in England and Wales not only for use in high-risk infants.PMID:36328884 | DOI:10.1016/j.vaccine.2022.10.041
Source: Vaccine - November 3, 2022 Category: Allergy & Immunology Authors: David Hodgson Mihaly Koltai Fabienne Krauer Stefan Flasche Mark Jit Katherine E Atkins Source Type: research
